Studying Different Formulations of SR13668 in Healthy Volunteers
NCT00896207
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
NIH
Sponsor class
Conditions
Healthy, no Evidence of Disease
Interventions
DRUG:
Akt inhibitor SR13668
Sponsor
National Cancer Institute (NCI)